- Home
- MSIF vs LENZ Comparison
MSIF vs LENZ Comparison
Compare MSIF & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSIF
- LENZ
- Stock Information
- Founded
- MSIF 2011
- LENZ 2019
- Country
- MSIF United States
- LENZ United States
- Employees
- MSIF N/A
- LENZ N/A
- Industry
- MSIF
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- MSIF
- LENZ Health Care
- Exchange
- MSIF NYSE
- LENZ Nasdaq
- Market Cap
- MSIF 795.9M
- LENZ 819.1M
- IPO Year
- MSIF N/A
- LENZ 2021
- Fundamental
- Price
- MSIF $16.20
- LENZ $35.48
- Analyst Decision
- MSIF Buy
- LENZ Strong Buy
- Analyst Count
- MSIF 5
- LENZ 5
- Target Price
- MSIF $18.50
- LENZ $41.80
- AVG Volume (30 Days)
- MSIF 85.1K
- LENZ 309.3K
- Earning Date
- MSIF 05-12-2025
- LENZ 05-07-2025
- Dividend Yield
- MSIF 8.90%
- LENZ N/A
- EPS Growth
- MSIF N/A
- LENZ N/A
- EPS
- MSIF 1.50
- LENZ N/A
- Revenue
- MSIF $134,105,000.00
- LENZ N/A
- Revenue This Year
- MSIF $9.98
- LENZ N/A
- Revenue Next Year
- MSIF $10.94
- LENZ $544.79
- P/E Ratio
- MSIF $10.89
- LENZ N/A
- Revenue Growth
- MSIF N/A
- LENZ N/A
- 52 Week Low
- MSIF $14.01
- LENZ $16.54
- 52 Week High
- MSIF $18.10
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- MSIF N/A
- LENZ 68.67
- Support Level
- MSIF N/A
- LENZ $31.01
- Resistance Level
- MSIF N/A
- LENZ $32.79
- Average True Range (ATR)
- MSIF 0.00
- LENZ 2.00
- MACD
- MSIF 0.00
- LENZ 0.48
- Stochastic Oscillator
- MSIF 0.00
- LENZ 93.76
About MSIF MSC INCOME FUND INC
MSC Income Fund Inc is a non-diversified closed-end management investment company. The investment objective is to generate current income through debt and equity investments and the secondary objective is to generate long-term capital appreciation through such investments. The company invests in senior secured term loans, second lien loans, and mezzanine debt and selected equity investments issued by lower middle-market and middle-market companies.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.